SCHEMBL645860

SCHEMBL645860

CC(CO)(Sc1cc(C(C)(C)C)c(O)c(C(C)(C)C)c1)Sc1cc(C(C)(C)C)c(O)c(C(C)(C)C)c1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALOX15 P16050 2/20 0.68
▸ MAPT P10636 2/20 0.68
▸ HPN P05981 1/20 0.68
▸ SIRT5 Q9NXA8 1/20 0.68
▸ VCAM1 P19320 10/20 0.53
▸ ALDH1A1 P00352 4/20 0.50
▸ LMNA P02545 2/20 0.50
▸ TSHR P16473 2/20 0.50
▸ MAPK1 P28482 2/20 0.50
▸ MEN1 O00255 1/20 0.50
▸ GMNN O75496 1/20 0.50
▸ GABBR2 O75899 1/20 0.50
▸ TP53 P04637 1/20 0.50
▸ CYP1A2 P05177 1/20 0.50
▸ CYP3A4 P08684 1/20 0.50
▸ CYP2C9 P11712 1/20 0.50
▸ NFKB1 P19838 1/20 0.50
▸ CYP2C19 P33261 1/20 0.50
▸ BLM P54132 1/20 0.50
▸ PMP22 Q01453 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL647467 0.85 ALOX15 (0.68) ALOX15MAPTHPNSIRT5VCAM1
SCHEMBL10504856 0.81 ALOX15 (0.63) ALOX15MAPTHPNSIRT5VCAM1
SCHEMBL648287 0.81 ALOX15 (0.63) ALOX15MAPTHPNSIRT5VCAM1
Probucol SCHEMBL4150 0.81 HPN (1.00) ALOX15MAPTHPNSIRT5VCAM1
Probucol SCHEMBL5143451 0.81 HPN (1.00) ALOX15MAPTHPNSIRT5VCAM1
Probucol SCHEMBL8344652 0.79 ALOX15 (0.95) ALOX15MAPTHPNSIRT5VCAM1
Probucol SCHEMBL4620631 0.79 ALOX15 (0.95) ALOX15MAPTHPNSIRT5VCAM1
SCHEMBL9506457 0.79 HPN (0.79) ALOX15MAPTHPNSIRT5VCAM1
SCHEMBL646329 0.79 HPN (0.59) ALOX15MAPTHPNSIRT5VCAM1
SCHEMBL12791592 0.78 ALOX15 (0.84) ALOX15MAPTHPNSIRT5VCAM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2070919-B1 SPIROQUINONE COMPOUND AND PHARMACEUTICAL COMPOSITION HYKES LAB LLC (JP) 2012-10-10 — — EP disclosed
US-8119686-B2 Spiroquinone compound and pharmaceutical composition HYKES LABORATORIES LLC (JP) 2012-02-21 — — US disclosed
US-20100056613-A1 SPIROQUINONE COMPOUND AND PHARMACEUTICAL COMPOSITION HYKES LABORATORIES LLC (JP) 2010-03-04 — — US disclosed
EP-2070919-A1 SPIROQUINONE COMPOUND AND PHARMACEUTICAL COMPOSITION Hykes Laboratories LLC (JP) 2009-06-17 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100056613-A1 SPIROQUINONE COMPOUND AND PHARMACEUTICAL COMPOSITION NR1H2, NR1H3, APOB ALOX15 2563/4885MAPT 4362/4885HPN 3356/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback